Detalhe da pesquisa
1.
Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome.
BMC Infect Dis
; 23(1): 78, 2023 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36747127
2.
Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)-mutant myelodysplastic syndromes subtype.
Br J Haematol
; 193(4): 798-803, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33765355
3.
Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients.
Blood
; 133(13): 1457-1464, 2019 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630862
4.
Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial.
Br J Haematol
; 190(3): 385-393, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32150297
5.
Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study.
Haematologica
; 103(9): 1484-1492, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29773602
6.
Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial.
Genes Chromosomes Cancer
; 56(7): 524-534, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28236351
7.
Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes.
Haematologica
; 102(2): 320-326, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27658438
8.
Dysplasia and PNH-type cells in bone marrow aspirates of myelodysplastic syndromes.
Cytometry B Clin Cytom
; 104(2): 162-172, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34806840
9.
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.
Blood Cancer J
; 13(1): 93, 2023 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37336890
10.
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.
Lancet Haematol
; 10(12): e966-e975, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922925
11.
Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS.
Blood Adv
; 4(18): 4267-4277, 2020 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32915972